Volume 141, Issue 3, Pages (September 2011)

Slides:



Advertisements
Similar presentations
Volume 33, Issue 2, Pages (August 2010)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 132, Issue 2, Pages (February 2007)
Volume 25, Issue 2, Pages (August 2006)
CD44 Deficiency Attenuates Chronic Murine Ileitis
Volume 137, Issue 3, Pages (September 2009)
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
Volume 133, Issue 5, Pages (November 2007)
Volume 143, Issue 5, Pages (November 2012)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 136, Issue 3, Pages (March 2009)
Volume 138, Issue 4, Pages (April 2010)
Volume 130, Issue 2, Pages (February 2006)
Volume 131, Issue 4, Pages (October 2006)
Volume 133, Issue 6, Pages (December 2007)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 141, Issue 2, Pages e4 (August 2011)
Volume 134, Issue 2, Pages (February 2008)
Volume 132, Issue 7, Pages (June 2007)
Making Sense of HDAC2 Mutations in Colon Cancer
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam,
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 142, Issue 4, Pages e9 (April 2012)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 132, Issue 3, Pages (March 2007)
Volume 155, Issue 4, Pages (October 2018)
Volume 141, Issue 3, Pages (September 2011)
Volume 119, Issue 6, Pages (December 2000)
Volume 132, Issue 7, Pages (June 2007)
Volume 137, Issue 3, Pages (September 2009)
Volume 128, Issue 5, Pages (May 2005)
Volume 140, Issue 7, Pages (June 2011)
Volume 137, Issue 5, Pages (November 2009)
Volume 28, Issue 4, Pages (April 2008)
Volume 139, Issue 3, Pages e3 (September 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 134, Issue 2, Pages (February 2008)
Volume 143, Issue 1, Pages (July 2012)
Volume 33, Issue 2, Pages (August 2010)
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 142, Issue 2, Pages (February 2012)
Volume 132, Issue 1, Pages (January 2007)
Volume 34, Issue 4, Pages (April 2011)
Volume 33, Issue 5, Pages (November 2010)
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 150, Issue 7, Pages (June 2016)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 142, Issue 5, Pages (May 2012)
Volume 119, Issue 3, Pages (September 2000)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 41, Issue 4, Pages (October 2014)
Volume 135, Issue 3, Pages (September 2008)
Volume 117, Issue 3, Pages (September 1999)
Volume 141, Issue 5, Pages (November 2011)
Covering the Cover Gastroenterology
Volume 46, Issue 4, Pages (April 2017)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 126, Issue 6, Pages (September 2006)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 41, Issue 2, Pages (August 2014)
Volume 13, Issue 6, Pages (June 2013)
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 127, Issue 3, Pages (September 2004)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 126, Issue 5, Pages (May 2004)
Presentation transcript:

Volume 141, Issue 3, Pages 1014-1023 (September 2011) Regulatory T Cells Suppress Development of Colitis, Blocking Differentiation of T-Helper 17 Into Alternative T-Helper 1 Cells  Tomohisa Sujino, Takanori Kanai, Yuichi Ono, Yohei Mikami, Atsushi Hayashi, Tomomitsu Doi, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Hiromasa Takaishi, Haruhiko Ogata, Akihiko Yoshimura, Dan R. Littman, Toshifumi Hibi  Gastroenterology  Volume 141, Issue 3, Pages 1014-1023 (September 2011) DOI: 10.1053/j.gastro.2011.05.052 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 RORγt+ Th1-like cells and RORγt− Th1 cells co-reside in inflamed mucosa of colitis. (A) Transfer protocol A. RAG-2−/− mice were transferred with RORγtgfp/+ CD4+CD25− T cells (Gr.2A, n = 6). Age-matched RORγtgfp/+ mice were used as a negative control (Gr.1A, n = 6). Mice were sacrificed 6 weeks after transfer. (B) Expression of IL-17A and IFN-γ in colonic CD3+CD4+ T cells. (C) Mean percentages of Th17, Th17/Th1, and Th1 cells (including Th1-like cells) in colonic LP CD3+CD4+ T cells. (D) Expression of IL-17A and IFN-γ in colonic GFP+ and GFP− CD3+CD4+ T cells of Gr.2A mice. (E) Mean percentages of colonic Th17, Th17/Th1, and Th1 cells in the GFP+ and GFP− CD3+CD4+ T cells of Gr.2A mice. (F) Expression of the indicated mRNA in the colonic CD3+CD4+ cells, normalized to Act-b expression. Statistical data (C, E, F) show mean ± standard error of mean (n = 6/group). *P < .05. NS, not significant. Gastroenterology 2011 141, 1014-1023DOI: (10.1053/j.gastro.2011.05.052) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 RORγt+T-bet+ Th1-like cells and RORγt−T-bet+ Th1 cells in colitic mice are colitogenic. (A) Transfer protocol B. RAG-2−/− mice were transferred with GFP+ (Gr.1B, n = 6) or GFP− (Gr.2B, n = 6) CD3+CD4+ T cells obtained from colitic Gr.2A mice in transfer protocol A (see Figure 1A). Mice were sacrificed 10 weeks after transfer. (B) Expression of GFP in colonic CD3+CD4+ T cells. (C) Percentage of GFP+ cells in colonic CD3+CD4+ T cells. (D) Expression of IL-17A and IFN-γ in colonic CD3+CD4+ T cells. Data are representative of six mice in each group. (E) Mean percentages of Th17, Th17/Th1, and Th1 cells (including Th1-like cells) in the colonic CD3+CD4+ T cells. (F) Expression of T-bet and IL-17A/IFN-γ in GFP+ and GFP− CD3+CD4+ T cells (T-bet, black; Isotype, gray). Statistical data (C, E) show mean ± standard error of mean (n = 6/group). *P < .05. NS, not significant. Gastroenterology 2011 141, 1014-1023DOI: (10.1053/j.gastro.2011.05.052) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 TR cells not only suppress the development of colitis but also induce the accumulation of Th17 and Th17/Th1 cells in noncolitic mice. (A) Transfer protocol C. RAG-2−/− mice were transferred with Ly5.1+CD4+CD45RBhigh T cells alone (Gr.1C, n = 6) or Ly5.1+CD4+CD45RBhigh T cells plus Ly5.2+CD4+CD25+ TR cells (Gr.2C, n = 6). Mice were sacrificed 7 weeks after transfer. (B-i) Expression of IL-17A and IFN-γ in colonic Ly5.1+CD3+CD4+ T cells. Data are representative of 6 mice in each group. (B-ii) Mean percentages of Th17, Th17/Th1, and Th1 cells (including Th1-like cells) in colonic CD3+CD4+ T cells. (C-i) Expression of IL-17A and TNF-α in colonic Ly5.1+CD3+CD4+ T cells. Data are representative of six mice in each group. (C-ii) Mean percentages of IL-17A+TNF-α−, IL-17A+TNF-α+, and IL-17A−TNF-α+ in colonic CD3+CD4+ T cells. (D-i) Expression of IL-17A and CTLA-4 in colonic Ly5.1+CD3+CD4+ T cells. Data are representative of 6 mice in each group. (D-ii) Mean percentages of IL-17A+CTLA-4−, IL-17A+CTLA-4+, and IL-17A−CTLA-4+ in colonic CD3+CD4+ T cells. (E) Expression of the indicated mRNA in colonic Ly.5.1+CD3+CD4+ T cells, normalized to Act-b expression. Statistical data (B-ii, C-ii, D-ii, E) show mean ± standard error of mean (n = 6/group). *P < .05. NS, not significant. Gastroenterology 2011 141, 1014-1023DOI: (10.1053/j.gastro.2011.05.052) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 TR cells suppress the development of colitis with the increase of RORγt+ cells. (A) Transfer protocol D. RAG-2−/− mice were transferred with Ly5.2+ RORγtgfp/+ CD4+CD45RBhigh T cells alone (Gr.1D, n = 6) or Ly5.2+ RORγtgfp/+ CD4+CD45RBhigh T cells plus Ly5.1+CD4+CD25+ TR cells (Gr.2D, n = 6). Mice were sacrificed 6 weeks after transfer. (B) Expression of GFP in colonic Ly5.2+ or Ly5.1+ CD3+CD4+ T cells. Data are representative of 6 mice in each group. (C) Percentage of GFP+ cells in colonic Ly5.2+ CD3+CD4+ T cells. (D) Expression of the indicated mRNA in GFP+ or GFP− CD3+CD4+ cells obtained from the colonic Ly.5.2+ CD3+CD4+ T cells of Gr.1D and Gr.2D mice, normalized to Act-b expression. (E) Expression of T-bet in GFP+ or GFP− colonic Ly5.2+CD3+CD4+ T cells of each group. Data are representative of 6 mice in each group. (F) Mean percentages of CTLA-4 in colonic IL-17A+IFN-γ− Th17, IL-17A+IFN-γ+ Th17/Th1, and IL-17A−IFN-γ+ Th1 cells. Statistical data (C, D, F) show mean ± standard error of mean (n = 6/group). *P < .05. NS, not significant. Gastroenterology 2011 141, 1014-1023DOI: (10.1053/j.gastro.2011.05.052) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 TR cells suppress the development of colitis induced by RORγt+ or RORγt− CD4+ T cells resided in noncolitic mice. (A) Transfer protocol E. RAG-2−/− mice were transferred with GFP+ or GFP− Ly5.2+CD4+ T cells obtained from noncolitic mice previously transferred with Ly5.2+CD4+CD45RBhigh T cells and Ly5.1+CD4+CD25+ TR cells with or without cotransfer of freshly isolated Ly5.1+CD4+CD25+ T cells from normal mice (Gr.1E-Gr.4E, each n = 6). Mice were sacrificed 6 weeks after transfer. (B) Change in body weight. *P < .05. (C) Histopathology of distal colon at 6 weeks after transfer. Original magnification, ×40. (D) Absolute cell number of recovered colonic LP CD3+CD4+ T cells at 6 weeks after transfer. (E) Expression of GFP in colonic Ly5.2+CD3+CD4+ T cells of each group. Data are representative of 6 mice in each group. (F) Mean percentages of GFP expression in colonic Ly5.2+CD3+CD4+ T cells of each group. Data (D, F) show mean ± standard error of mean (n = 6/group). *P < .05. NS, not significant. Gastroenterology 2011 141, 1014-1023DOI: (10.1053/j.gastro.2011.05.052) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 TR cells modulate the balance between Th17 and Th1 cells. (A) Transfer protocol F. RAG-2−/− mice were transferred with colitogenic CD4+ T cells obtained from colitic mice previously transferred with Ly5.1+CD4+CD45RBhigh T cells with (Gr.2F, n = 6) or without (Gr.1F, n = 6) Ly5.2+CD4+CD25+ TR cells. Mice were sacrificed 6 weeks after transfer. (B) Expression of IL-17A and IFN-γ in the originally transferred LP Ly5.1+CD3+CD4+ T cells and Ly5.1+CD3+CD4+ T cells isolated from the colon. Data are representative of 6 mice in each group. (C) Mean percentages of Th17, Th17/Th1, and Th1 cells (including Th1-like cells) in the originally transferred LP Ly5.1+CD3+CD4+ T cells and Ly5.1+CD3+CD4+ T cells isolated from the colon of Gr.1F or Gr.2F mice. (D) Ratio of Th17 to Th1 cells in LP Ly5.1+CD3+CD4+ T cells. (E) Expression of IL-17A and CTLA-4 in colonic Ly5.1+CD3+CD4+ T cells. Data are representative of six mice in each group. (F) Mean percentages of IL-17A+CTLA-4−, IL-17A+CTLA-4+, and IL-17A−CTLA-4+ in Ly5.1+CD3+CD4+ T cells isolated from the originally transferred LP Ly5.1+CD3+CD4+ T cells and Ly5.1+CD3+CD4+ T cells isolated from the colon of Gr.1F or Gr.2F mice. Statistical data (C, D, F) show mean ± standard error of mean (n = 6/group). *P < .05. Gastroenterology 2011 141, 1014-1023DOI: (10.1053/j.gastro.2011.05.052) Copyright © 2011 AGA Institute Terms and Conditions